Previous research has demonstrated that sorafenib can induce a shift in tumor-associated macrophage (TAM) phenotype towards a pro-inflammatory state, thereby promoting NK cell activation in a cytokine- and NF-κB-dependent manner [29]. The gene discussed is NFKB1; the disease is neoplasm.